Table 4.
Cell-Growth Inhibition of Bistramide Stereochemical Analogs 1.1–1.36 Against UO-31 and SF-295 Cancer Cell Lines.
| compound | UO-31 (IC50 ± SEM µM) | SF-295 (IC50 ± SEM µM) |
|---|---|---|
| 1.1 | 0.071 ± 0.01 | 0.47 ± 0.2 |
| 1.2 | 5.9± 1.1 | _a |
| 1.3 | 45 ± 8 | 78.8 ± 4 |
| 1.4 | 4.6 ± 0.7 | 4.7 ± 2 |
| 1.5 | 0.62± 0.03 | 2 ± 0 |
| 1.6 | 14.8 ± 4.5 | _a |
| 1.7 | 45.3 ± 0.5 | 76.5 |
| 1.8 | 15.9 ± 7.3 | _a |
| 1.9 | 0.32 ± 0.02 | 0.2 ± 0.0 |
| 1.10 | 15.6 ± 4.5 | _a |
| 1.11 | 17.1 ± 2.2 | _a |
| 1.12 | 2.8 ± 0.4 | _a |
| 1.13 | 1.9 ± 0.2 | ~2.4b |
| 1.14 | 7.8 ± 3.5 | 77.5 ± 4 |
| 1.15 | 18.2 ± 5.8 | _a |
| 1.16 | 11 ± 1.4 | ~96b |
| 1.17 | 0.33 ± 0.02 | 3.5 |
| 1.18 | 13.9 ± 5.3 | _a |
| 1.19 | 44.7 ± 9.7 | _a |
| 1.20 | 14.5 ± 5 | ~14b |
| 1.21 | 0.044 ± 0.017 | ~3.8b |
| 1.22 | 44.7 ± 20.7 | _a |
| 1.23 | 6.2 ± 0.5 | 17.1 ± 6 |
| 1.24 | 45.1 ± 30.8 | 75.2 |
| 1.25 | 5.7 ± 0.7 | ~34b |
| 1.26 | 0.82 ± 0.07 | ~30b |
| 1.27 | 17.4 ± 6.4 | _a |
| 1.28 | 15 ± 9.9 | _a |
| 1.29 | 0.81 ± 0.08 | ~20b |
| 1.30 | 14.9 ± 0.4 | _a |
| 1.31 | 14.6 ± 10.2 | _a |
| 1.32 | 5.3 ± 1.4 | _a |
| 1.33 | 0.33 ± 0.04 | 0.34 ± 0.1 |
| 1.34 | 12 ± 1.7 | _a |
| 1.35 | 15.4 ± 9.3 | _a |
| 1.36 | 2.2 ± 0.3 | ~16b |
Compounds were not tested.
Estimated IC50 value.